Contacts

Ross McNaughton

Partner

Read More

Oli Denne

Senior Associate

Read More
Contacts

Ross McNaughton

Partner

Read More

Oli Denne

Senior Associate

Read More

20 March 2024

Advising on Mission Zero Technologies on its £21.8 million Series A funding

We have advised 2150, World Fund, Fortescue and Siemens Financial Services on their Series A investment into Mission Zero, a developer for direct air capture technology. 

Mission Zero is one of the pioneers in the direct air capture (DAC) space to have moved beyond self-financed R&D pilot plants to commercially funded deployments with international customers. Since 2020, the company have been working to scale a versatile technology capable of efficiently recovering CO₂ from the atmosphere. Its goal is to reinvent people's relationship with carbon for a thriving planet — rebalancing climate and unlocking a new, sustainable carbon source to replace fossil fuels.

The investment is intended to catalyse Mission Zero's growth by accelerating the development of a mass deployable DAC product with a recovery capacity of 1,000 tCO₂ per year. By the end of 2024, the company aims to have three fully-funded first-of-a-kind systems on the ground in projects pioneering CO₂ mineralisation, carbon-negative building materials, and sustainable aviation fuel.

Commenting on the transaction, corporate partner Ross McNaughton said: "It's been a great pleasure to work with the investment syndicate on this transaction, and to see their continued mission-driven investments in companies like Mission Zero, who are looking to either permanently remove or use CO2 to displace fossil carbons in products and processes. As a firm at Taylor Wessing, we have our own commitments to sustainability which we take incredibly seriously, and being able to support on transactions like this that have the potential for transformational change, is truly rewarding."

Christian Jolck, co-founder and partner at 2150 added: "2150 was formed with the view to tackling the biggest sustainability challenge on the planet and to change how our cities are designed, constructed and powered, for good. We are excited to announce our investment into Mission Zero, whose work has the potential to bring the level of CO2 emissions down at a gigatonne scale. We are grateful to the Taylor Wessing team for once again expertly supporting and guiding us through this complex transaction and ensuring that it progressed smoothly."

The deal was led by partner Ross McNaughton and senior associate Oli Denne from the Corporate team. Further support was provided by:

Corporate team
Associate Nadege Serna

Employment, Pensions and Mobility teams
Partner Helen Farr and senior associate Jordan Buckle 

Patents team
Partner Adrian Toutoungi and senior associate Sebastian Allen-Johnstone

Tax and Incentives teams
Partner Claire Matthews and senior counsel Katie Lewis

Technology, IP and Information teams 
Trainee Clover May

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

Corporate/M&A & capital markets

Nuclera raises additional capital for eProtein™ desktop bioprinter to close Series B funding at $58 million

14 July 2022

by multiple authors

Click here to find out more
Corporate/M&A & capital markets

Advising New Science Ventures as lead investor on Paragraf's $60 million Series B funding round

4 March 2022

by Ross McNaughton and Adrian Toutoungi

Click here to find out more
Life sciences & healthcare

Advising Nuclera on its Series B funding round

2 February 2022

by multiple authors

Click here to find out more